The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer

To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ONCOTARGET 2017-09, Vol.8 (37), p.62183-62194
Hauptverfasser: Hilborn, Erik, Stål, Olle, Alexeyenko, Andrey, Jansson, Agneta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62194
container_issue 37
container_start_page 62183
container_title ONCOTARGET
container_volume 8
creator Hilborn, Erik
Stål, Olle
Alexeyenko, Andrey
Jansson, Agneta
description To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased expression and had a time-dependent effect on . This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased expression, with limited effect on expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The up-regulated , while and had up- and down-regulatory effect and reduced expression. The and reduced expression. Downregulation of CX3CL1, EPHB6, and TP63 increased and , while downregulation suppressed and promoted expression. We show that and are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.
doi_str_mv 10.18632/oncotarget.19136
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_493602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1947614580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxiMEolXpA3BBPnLYlEziOPEFadXyT6pAQoWr5diTXUPWXmwHmtfizivwTHizS-le8MXW-JvfjD59WfYUigtoWVW-cFa5KP0K4wVwqNiD7BQ45XlZ19XDe--T7DyEL0U6NW3akj_OTsqWNw2v2Gn262aNxONqHGQ0zhLXk_WkvbudQkTvjCbQ_P6Za5yrK7QyIInTFgkQaTUpSaohwdutxxB2BGNJ51GGSJS0Cj1ROAxkMBYD6SaCIXqpjRsWRJsZGlPJzdMsLsjGKO8-vl-Gxczf0UNaMK2HmkR3zH6SPerlEPD8cJ9ln16_url8m19_ePPucnmdK1qVMe8RZY8KOVMIfaeQsQYAu043VcsLDXUNFJXk0BUIqm26jsm2p7Kgqu57WZ1l-Z4bfuB27MTWm430k3DSiEPpa3qhoMnUovyv_sp8XgrnV2IwowAKUBZJ_3KvT-INaoU2mTQctR3_WLMWK_dd1AwaylkCPD8AvPs2JkPFxoSd8dKiG4NIYWgY0LrdzYK9NPkcgsf-bgwUYk6W-JcsMScr9Ty7v99dx98cVX8Ak93VQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1947614580</pqid></control><display><type>article</type><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><source>SWEPUB Freely available online</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</creator><creatorcontrib>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</creatorcontrib><description>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased expression and had a time-dependent effect on . This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased expression, with limited effect on expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The up-regulated , while and had up- and down-regulatory effect and reduced expression. The and reduced expression. Downregulation of CX3CL1, EPHB6, and TP63 increased and , while downregulation suppressed and promoted expression. We show that and are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.19136</identifier><identifier>PMID: 28977936</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>ONCOTARGET, 2017-09, Vol.8 (37), p.62183-62194</ispartof><rights>Copyright: © 2017 Hilborn et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</citedby><cites>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617496/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617496/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,552,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28977936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141120$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:136597931$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Hilborn, Erik</creatorcontrib><creatorcontrib>Stål, Olle</creatorcontrib><creatorcontrib>Alexeyenko, Andrey</creatorcontrib><creatorcontrib>Jansson, Agneta</creatorcontrib><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><title>ONCOTARGET</title><addtitle>Oncotarget</addtitle><description>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased expression and had a time-dependent effect on . This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased expression, with limited effect on expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The up-regulated , while and had up- and down-regulatory effect and reduced expression. The and reduced expression. Downregulation of CX3CL1, EPHB6, and TP63 increased and , while downregulation suppressed and promoted expression. We show that and are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>D8T</sourceid><recordid>eNp9ks9u1DAQxiMEolXpA3BBPnLYlEziOPEFadXyT6pAQoWr5diTXUPWXmwHmtfizivwTHizS-le8MXW-JvfjD59WfYUigtoWVW-cFa5KP0K4wVwqNiD7BQ45XlZ19XDe--T7DyEL0U6NW3akj_OTsqWNw2v2Gn262aNxONqHGQ0zhLXk_WkvbudQkTvjCbQ_P6Za5yrK7QyIInTFgkQaTUpSaohwdutxxB2BGNJ51GGSJS0Cj1ROAxkMBYD6SaCIXqpjRsWRJsZGlPJzdMsLsjGKO8-vl-Gxczf0UNaMK2HmkR3zH6SPerlEPD8cJ9ln16_url8m19_ePPucnmdK1qVMe8RZY8KOVMIfaeQsQYAu043VcsLDXUNFJXk0BUIqm26jsm2p7Kgqu57WZ1l-Z4bfuB27MTWm430k3DSiEPpa3qhoMnUovyv_sp8XgrnV2IwowAKUBZJ_3KvT-INaoU2mTQctR3_WLMWK_dd1AwaylkCPD8AvPs2JkPFxoSd8dKiG4NIYWgY0LrdzYK9NPkcgsf-bgwUYk6W-JcsMScr9Ty7v99dx98cVX8Ak93VQg</recordid><startdate>20170922</startdate><enddate>20170922</enddate><creator>Hilborn, Erik</creator><creator>Stål, Olle</creator><creator>Alexeyenko, Andrey</creator><creator>Jansson, Agneta</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ABXSW</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG8</scope><scope>ZZAVC</scope></search><sort><creationdate>20170922</creationdate><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><author>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Hilborn, Erik</creatorcontrib><creatorcontrib>Stål, Olle</creatorcontrib><creatorcontrib>Alexeyenko, Andrey</creatorcontrib><creatorcontrib>Jansson, Agneta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Linköpings universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Linköpings universitet</collection><collection>SwePub Articles full text</collection><jtitle>ONCOTARGET</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hilborn, Erik</au><au>Stål, Olle</au><au>Alexeyenko, Andrey</au><au>Jansson, Agneta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</atitle><jtitle>ONCOTARGET</jtitle><addtitle>Oncotarget</addtitle><date>2017-09-22</date><risdate>2017</risdate><volume>8</volume><issue>37</issue><spage>62183</spage><epage>62194</epage><pages>62183-62194</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased expression and had a time-dependent effect on . This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased expression, with limited effect on expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The up-regulated , while and had up- and down-regulatory effect and reduced expression. The and reduced expression. Downregulation of CX3CL1, EPHB6, and TP63 increased and , while downregulation suppressed and promoted expression. We show that and are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>28977936</pmid><doi>10.18632/oncotarget.19136</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof ONCOTARGET, 2017-09, Vol.8 (37), p.62183-62194
issn 1949-2553
1949-2553
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_493602
source SWEPUB Freely available online; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals
subjects Research Paper
title The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A33%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20regulation%20of%20hydroxysteroid%2017%CE%B2-dehydrogenase%20type%201%20and%202%20gene%20expression%20in%20breast%20cancer%20cell%20lines%20by%20estradiol,%20dihydrotestosterone,%20microRNAs,%20and%20genes%20related%20to%20breast%20cancer&rft.jtitle=ONCOTARGET&rft.au=Hilborn,%20Erik&rft.date=2017-09-22&rft.volume=8&rft.issue=37&rft.spage=62183&rft.epage=62194&rft.pages=62183-62194&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.19136&rft_dat=%3Cproquest_swepu%3E1947614580%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1947614580&rft_id=info:pmid/28977936&rfr_iscdi=true